Immediate Action Required: Send Mpox Skin Lesion Samples for Testing

Urgent Directive on Mpox Testing for States and Union Territories

In a recent communication, Union Health Secretary Apurva Chandra has emphasized the importance of quick action regarding the monitoring and testing of mpox (formerly known as monkeypox). To ensure efficient management of potential mpox cases, he has instructed states and Union territories to take the following steps:

• Sample Collection: Health authorities are to collect samples from skin lesions of any patient exhibiting symptoms consistent with mpox.
• Testing Protocol: These samples must be sent immediately to designated laboratories equipped to conduct mpox tests.
• Genome Sequencing: Should any sample test positive for mpox, it will be forwarded to the Indian Council of Medical Research-National Institute of Virology (ICMR-NIV) for thorough genome sequencing.

Importance of Rapid Response

This directive is vital for the timely identification and management of mpox cases, which could help prevent further spread of the virus. By adhering to these protocols, health departments play a crucial role in:

• Enhancing public health safety.
• Allowing for accurate tracking of mpox variants.
• Providing essential data to inform future health strategies.

Key Takeaway

States and Union territories are urged to act swiftly in sending skin lesion samples for mpox testing. This proactive approach is critical in combating the risks associated with mpox and safeguarding community health across India. For any inquiries or further information, health officials are encouraged to stay connected with the ICMR-NIV and follow their guidance closely.

By working together and following these recommendations, we can enhance our capabilities to manage and control mpox effectively.